Massimo Autunno

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Systematic Review

Newly Diagnosed

Monoclonal Antibody

Transcranial Magnetic Stimulation

Top Venues

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Giacomo Iabichella, Massimo Autunno, Salvatore Bertino, Angelina Laganà, Angelo Labate
Efficacy of lamotrigine in migralepsy: a case report. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2024)
Giacomo Iabichella, Massimo Autunno, Salvatore Bertino, Angelina Laganà, Angelo Labate
Efficacy of lamotrigine in migralepsy: a case report. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 45 (5) (2024)
Barbanti Piero, Bianca Orlando, Gabriella Egeo, Florindo d'Onofrio, Alberto Doretti, Stefano Messina, Massimo Autunno, Roberta Messina, Massimo Filippi, Giulia Fiorentini, Cristina Rotondi, Stefano Bonassi, Cinzia Aurilia
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study. Brain sciences 14 (7) (2024)
Giacomo Iabichella, Massimo Autunno, Salvatore Bertino, Angelina Laganà, Angelo Labate
Efficacy of lamotrigine in migralepsy: a case report. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 45 (5) (2024)
Barbanti Piero, Bianca Orlando, Gabriella Egeo, Florindo d'Onofrio, Alberto Doretti, Stefano Messina, Massimo Autunno, Roberta Messina, Massimo Filippi, Giulia Fiorentini, Cristina Rotondi, Stefano Bonassi, Cinzia Aurilia
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study. Brain sciences 14 (7) (2024)
Barbanti Piero, Bianca Orlando, Gabriella Egeo, Florindo d'Onofrio, Alberto Doretti, Stefano Messina, Massimo Autunno, Roberta Messina, Massimo Filippi, Giulia Fiorentini, Cristina Rotondi, Stefano Bonassi, Cinzia Aurilia
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study. Brain sciences 14 (7) (2024)
Laura Pilati, Angelo Torrente, Salvatore Di Marco, Salvatore Ferlisi, Giulia Notaro, Marika Romano, Paolo Alonge, Lavinia Vassallo, Ludovica Ferraù, Massimo Autunno, Rosario Grugno, Cecilia Camarda, Filippo Brighina
Erenumab and Possible CGRP Effect on Chronotype in Chronic Migraine: A Real-Life Study of 12 Months Treatment. Journal of clinical medicine 12 (10) (2023)